Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroencephalography | 18 | 2021 | 418 | 3.060 |
Why?
|
| Seizures | 6 | 2021 | 279 | 2.390 |
Why?
|
| Epilepsy | 9 | 2019 | 336 | 1.650 |
Why?
|
| Status Epilepticus | 6 | 2019 | 74 | 1.350 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 371 | 1.130 |
Why?
|
| Anticonvulsants | 5 | 2007 | 223 | 1.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2019 | 36 | 0.680 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 29 | 0.680 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2018 | 8 | 0.660 |
Why?
|
| Physical Stimulation | 1 | 2017 | 67 | 0.580 |
Why?
|
| Pancreatitis | 1 | 2018 | 279 | 0.560 |
Why?
|
| Artifacts | 1 | 2017 | 125 | 0.560 |
Why?
|
| Somatosensory Cortex | 1 | 2015 | 22 | 0.530 |
Why?
|
| Carbamazepine | 3 | 2003 | 108 | 0.490 |
Why?
|
| Brain Mapping | 2 | 2015 | 531 | 0.480 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2015 | 211 | 0.460 |
Why?
|
| Preoperative Care | 1 | 2015 | 275 | 0.460 |
Why?
|
| Brain | 5 | 2019 | 2175 | 0.450 |
Why?
|
| White Matter | 1 | 2015 | 174 | 0.430 |
Why?
|
| Epilepsies, Partial | 4 | 2007 | 24 | 0.420 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2011 | 40 | 0.380 |
Why?
|
| Fructose | 2 | 2007 | 51 | 0.360 |
Why?
|
| Monitoring, Ambulatory | 1 | 2010 | 84 | 0.350 |
Why?
|
| Humans | 29 | 2021 | 68525 | 0.330 |
Why?
|
| Facial Muscles | 1 | 2007 | 11 | 0.320 |
Why?
|
| Myoclonus | 1 | 2007 | 9 | 0.320 |
Why?
|
| Male | 18 | 2021 | 37281 | 0.310 |
Why?
|
| Dyslexia | 1 | 2007 | 17 | 0.300 |
Why?
|
| Prevalence | 2 | 2021 | 1609 | 0.270 |
Why?
|
| Retrospective Studies | 6 | 2021 | 7264 | 0.260 |
Why?
|
| Middle Aged | 10 | 2021 | 21119 | 0.260 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2017 | 100 | 0.250 |
Why?
|
| Female | 14 | 2021 | 38015 | 0.240 |
Why?
|
| Nocturnal Myoclonus Syndrome | 1 | 2003 | 3 | 0.230 |
Why?
|
| Placebo Effect | 1 | 2003 | 20 | 0.230 |
Why?
|
| Arousal | 1 | 2003 | 168 | 0.220 |
Why?
|
| Adult | 12 | 2021 | 21375 | 0.220 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 2798 | 0.220 |
Why?
|
| Leg | 1 | 2003 | 191 | 0.210 |
Why?
|
| Aged | 7 | 2021 | 14842 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2003 | 929 | 0.200 |
Why?
|
| Sleep | 1 | 2003 | 263 | 0.190 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 396 | 0.180 |
Why?
|
| Adolescent | 7 | 2011 | 8903 | 0.180 |
Why?
|
| Scalp | 1 | 2019 | 47 | 0.170 |
Why?
|
| Child | 7 | 2011 | 6400 | 0.170 |
Why?
|
| Child, Preschool | 4 | 2011 | 3185 | 0.150 |
Why?
|
| Electric Power Supplies | 1 | 2016 | 26 | 0.150 |
Why?
|
| Brain Waves | 1 | 2016 | 30 | 0.150 |
Why?
|
| Malformations of Cortical Development | 1 | 2015 | 7 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1054 | 0.130 |
Why?
|
| Software | 2 | 2017 | 418 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2019 | 2356 | 0.110 |
Why?
|
| Intensive Care Units | 1 | 2014 | 344 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3256 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1851 | 0.100 |
Why?
|
| Observer Variation | 3 | 2018 | 330 | 0.100 |
Why?
|
| Turkey | 1 | 2011 | 7 | 0.100 |
Why?
|
| Infant | 3 | 2010 | 2891 | 0.100 |
Why?
|
| Time Factors | 1 | 2019 | 4655 | 0.100 |
Why?
|
| Artificial Intelligence | 1 | 2012 | 159 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2011 | 204 | 0.090 |
Why?
|
| Reading | 1 | 2007 | 19 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2007 | 2222 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1465 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 1753 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2007 | 240 | 0.070 |
Why?
|
| Algorithms | 3 | 2018 | 1194 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2077 | 0.070 |
Why?
|
| Electromyography | 2 | 2003 | 184 | 0.060 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2004 | 3 | 0.060 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2004 | 21 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 137 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 361 | 0.060 |
Why?
|
| Insulin | 1 | 2007 | 617 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2007 | 631 | 0.060 |
Why?
|
| Positive-Pressure Respiration | 1 | 2003 | 27 | 0.060 |
Why?
|
| Drug Tolerance | 1 | 2003 | 80 | 0.060 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2003 | 28 | 0.060 |
Why?
|
| Safety | 1 | 2003 | 145 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2003 | 129 | 0.060 |
Why?
|
| Polysomnography | 1 | 2003 | 92 | 0.060 |
Why?
|
| Sodium | 1 | 2003 | 161 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2003 | 223 | 0.050 |
Why?
|
| Tibia | 1 | 2003 | 93 | 0.050 |
Why?
|
| Penis | 2 | 1999 | 25 | 0.050 |
Why?
|
| Epilepsy, Frontal Lobe | 1 | 2001 | 2 | 0.050 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2002 | 7 | 0.050 |
Why?
|
| Epilepsy, Generalized | 1 | 2001 | 15 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2004 | 506 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2003 | 142 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2003 | 7028 | 0.050 |
Why?
|
| Electrodes | 2 | 2016 | 147 | 0.050 |
Why?
|
| Impotence, Vasculogenic | 1 | 1999 | 2 | 0.040 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 1999 | 14 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 848 | 0.040 |
Why?
|
| Diabetic Neuropathies | 1 | 1999 | 33 | 0.040 |
Why?
|
| Neurologists | 1 | 2018 | 15 | 0.040 |
Why?
|
| Hospitals, Private | 1 | 2018 | 15 | 0.040 |
Why?
|
| Research Design | 1 | 2003 | 729 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2018 | 70 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2018 | 75 | 0.040 |
Why?
|
| Cognition | 1 | 2002 | 512 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 1999 | 249 | 0.040 |
Why?
|
| Age Factors | 1 | 2001 | 1860 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2016 | 81 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 281 | 0.040 |
Why?
|
| Reference Values | 1 | 2016 | 579 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 4843 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 2323 | 0.030 |
Why?
|
| Veterans | 1 | 2016 | 904 | 0.020 |
Why?
|
| Evoked Potentials | 2 | 1999 | 61 | 0.020 |
Why?
|
| Pentobarbital | 1 | 2004 | 19 | 0.020 |
Why?
|
| Aphasia, Wernicke | 1 | 2004 | 3 | 0.020 |
Why?
|
| GABA Modulators | 1 | 2004 | 26 | 0.020 |
Why?
|
| Plasma | 1 | 2004 | 58 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2004 | 164 | 0.020 |
Why?
|
| Animals | 1 | 2002 | 20877 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2004 | 334 | 0.020 |
Why?
|
| Time | 1 | 2003 | 57 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2004 | 156 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 648 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 1737 | 0.010 |
Why?
|
| Penile Erection | 1 | 1999 | 18 | 0.010 |
Why?
|
| Galvanic Skin Response | 1 | 1999 | 67 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 117 | 0.010 |
Why?
|
| Reaction Time | 1 | 1999 | 170 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1999 | 693 | 0.010 |
Why?
|